Assessment scales for depression: the next 20 years.

Assessment scales for depression: the next 20 years. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Assessment scales for depression: the next 20 years. Abstract Text:

P Bech,

Assessment scales for depression: the next 20 years. Publishing Authors By Initials

P Bech,

For similar behavioral disciplines and activities: psychological tests: psychometrics research abstracts see: behavioral disciplines and activities: psychological tests: psychometrics research

PUBMED ID PMID:

MEDLINE DATE:

Assessment scales for depression: the next 20 years. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Acta psychiatrica Scandinavica. Supplementum

VOLUME: 310

Page Numbers: 117-30

Journal Abbreviation:

ISSN: 0065-1591

DAY: 15

MONTH: 02

YEAR: 1983

Assessment scales for depression: the next 20 years. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370365

Assessment scales for depression: the next 20 years. Keywords Mesh Terms:

KEYWORDS: Psychometrics

MESH TERMS: standards

Chemical & Substance for Abstract: Assessment scales for depression: the next 20 years. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Assessment scales for depression: the next 20 years.

AFFILIATION:

Country: DENMARK

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Acta Psychiatr Scand Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Assessment scales for depression: the next 20 years Related Publications

• Adding biphasic insulin aspart 30 once or twice daily is more efficacious than optimizing oral antidiabetic treatment in patients with type 2 diabetes.
• Assessment scales for depression: the next 20 years.
• Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
• Concentrations of heavy metals in urban soils of Talcahuano (Chile): a preliminary study.
• Cytomegaly of the foetal adrenal cortex.
• Escitalopram, problem-solving therapy, and poststroke depression.
• Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
• Metabolic adjustments in breeding female kittiwakes (Rissa tridactyla) include changes in kidney metabolic intensity.
• Patient preferences for pharmacogenetic screening in depression.
• Prediction of spatial perceptual attributes of reproduced sound across the listening area.
• Quality of life assessment in schizophrenia: Applicability of the Lehman Quality of Life Questionnaire (TL-30).
• Rating scales for affective disorders: their validity and consistency.
• Rating scales for mood disorders: applicability, consistency and construct validity.
• Repetitive Transcranial Magnetic Stimulation (rTMS) in Combination with Escitalopram in Patients with Treatment-Resistant Major Depression. A Double-Blind, Randomised, Sham-Controlled Trial.
• Why did some Danish counties introduce breast cancer screening and others not? An exploratory study of four selected counties.
• [Fatigue in chronic disease--a bibliographic study of research in disease-related fatigue across medical specialties]
• [Quality of life concept]